ATE499114T1 - Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen - Google Patents
Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungenInfo
- Publication number
- ATE499114T1 ATE499114T1 AT03764286T AT03764286T ATE499114T1 AT E499114 T1 ATE499114 T1 AT E499114T1 AT 03764286 T AT03764286 T AT 03764286T AT 03764286 T AT03764286 T AT 03764286T AT E499114 T1 ATE499114 T1 AT E499114T1
- Authority
- AT
- Austria
- Prior art keywords
- erythropoiety
- compositions containing
- medicinal compositions
- stabilized aqueous
- aqueous medicinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200200178A SI21258A (sl) | 2002-07-17 | 2002-07-17 | Stabilni farmacevtski pripravek, ki vsebuje eritropoietin in poloksamerni poliol |
PCT/SI2003/000023 WO2004006958A1 (en) | 2002-07-17 | 2003-07-14 | Stable pharmaceutical composition comprising erythropoietin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE499114T1 true ATE499114T1 (de) | 2011-03-15 |
Family
ID=30113492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03764286T ATE499114T1 (de) | 2002-07-17 | 2003-07-14 | Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US7534870B2 (de) |
EP (1) | EP1524998B1 (de) |
JP (1) | JP2005535673A (de) |
CN (1) | CN1668333A (de) |
AT (1) | ATE499114T1 (de) |
AU (1) | AU2003251284B2 (de) |
CA (1) | CA2492485A1 (de) |
DE (1) | DE60336142D1 (de) |
MX (1) | MXPA05000662A (de) |
SI (1) | SI21258A (de) |
WO (1) | WO2004006958A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004244920B2 (en) * | 2003-06-10 | 2009-07-23 | Lg Chem, Ltd. | Stable, aqueous solution of human erythropoietin, not containing serum albumin |
CN100342909C (zh) * | 2005-05-11 | 2007-10-17 | 北京双鹭药业股份有限公司 | 一种胸腺素α1的水溶液制剂、其制备方法及应用 |
JP5553506B2 (ja) * | 2006-03-22 | 2014-07-16 | 中外製薬株式会社 | エリスロポエチン溶液製剤 |
JP2011116752A (ja) * | 2009-10-29 | 2011-06-16 | Jcr Pharmaceuticals Co Ltd | エリスロポエチン含有水性液剤 |
US8829163B2 (en) * | 2010-01-19 | 2014-09-09 | Hanmi Science Co., Ltd | Liquid formulations for long-acting erythropoietin conjugate |
WO2015200526A1 (en) * | 2014-06-25 | 2015-12-30 | Bio-Rad Laboratories, Inc. | Purification of nanoparticle-antibody conjugates |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6191131A (ja) | 1984-10-09 | 1986-05-09 | Chugai Pharmaceut Co Ltd | 医薬品の吸着防止方法および組成物 |
GB8822857D0 (en) * | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
WO1995033474A1 (fr) * | 1994-06-03 | 1995-12-14 | Tsumura & Co. | Composition medicinale |
US6284234B1 (en) | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
US7163671B2 (en) * | 2000-02-29 | 2007-01-16 | Chugai Seiyaku Kabushiki Kaisha | Long-term stabilized formulations |
DK1311285T4 (en) * | 2000-05-15 | 2017-07-24 | Hoffmann La Roche | Liquid pharmaceutical composition containing an erythropoietin derivative |
AU2001273034A1 (en) * | 2000-06-26 | 2002-01-08 | Rxkinetix, Inc. | Composition for delivery of hematopoietic growth factor |
-
2002
- 2002-07-17 SI SI200200178A patent/SI21258A/sl not_active IP Right Cessation
-
2003
- 2003-07-14 WO PCT/SI2003/000023 patent/WO2004006958A1/en active IP Right Grant
- 2003-07-14 CN CNA038170078A patent/CN1668333A/zh active Pending
- 2003-07-14 AU AU2003251284A patent/AU2003251284B2/en not_active Ceased
- 2003-07-14 EP EP03764286A patent/EP1524998B1/de not_active Expired - Lifetime
- 2003-07-14 AT AT03764286T patent/ATE499114T1/de not_active IP Right Cessation
- 2003-07-14 MX MXPA05000662A patent/MXPA05000662A/es active IP Right Grant
- 2003-07-14 US US10/521,298 patent/US7534870B2/en not_active Expired - Fee Related
- 2003-07-14 CA CA002492485A patent/CA2492485A1/en not_active Abandoned
- 2003-07-14 JP JP2004521371A patent/JP2005535673A/ja active Pending
- 2003-07-14 DE DE60336142T patent/DE60336142D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
MXPA05000662A (es) | 2005-08-19 |
US20050202091A1 (en) | 2005-09-15 |
US7534870B2 (en) | 2009-05-19 |
SI21258A (sl) | 2004-02-29 |
JP2005535673A (ja) | 2005-11-24 |
EP1524998A1 (de) | 2005-04-27 |
WO2004006958A1 (en) | 2004-01-22 |
AU2003251284B2 (en) | 2007-08-02 |
AU2003251284B9 (en) | 2004-02-02 |
WO2004006958A8 (en) | 2005-01-13 |
DE60336142D1 (de) | 2011-04-07 |
CN1668333A (zh) | 2005-09-14 |
CA2492485A1 (en) | 2004-01-22 |
AU2003251284A1 (en) | 2004-02-02 |
EP1524998B1 (de) | 2011-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1086706T3 (da) | Stabiliserede sammensætninger indeholdende nootropiske lægemidler | |
SV2003001106A (es) | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco ref.pc11846 | |
CR8824A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica | |
UY27320A1 (es) | Nuevas composiciones farmacéuticas | |
BR0307541A (pt) | Composição para cuidado pessoal e composição cosmética | |
HN2002000300A (es) | Nuevos derivados de piperazina | |
ID26033A (id) | Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan | |
ES2062310T3 (es) | Un procedimiento para fabricar un preparado farmaceutico acuoso estabilizado. | |
DE60334773D1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
DE60114171D1 (de) | Minoxidil enthaltende zubereitung | |
BRPI0312882B8 (pt) | derivados de pleuromutilina e composição farmacêutica | |
BR0212386A (pt) | Composto, formulação farmacêutica, e, uso de um composto | |
BR0209283A (pt) | Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme | |
EE200300476A (et) | 4-tsüanotrifluoro-3-(4-fluorofenüülsulfonüül)-2-hüdroksü-2-metüülpropiono-m-toluidii di ja PVP-d sisaldav tahke farmatseutiline kompositsioon | |
BR0111678A (pt) | Composições medicinais contendo derivados de propenona | |
AR029509A1 (es) | Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales | |
ATE499114T1 (de) | Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen | |
BRPI0403461A (pt) | composições estabilizadas contendo um agente ativo lábil ao oxigênio | |
ATE318575T1 (de) | Orale zubereitung chlorhexidin und maltitol oder erythritol oder deren mischung enthaltend | |
CO5580729A2 (es) | Composiciones nutricionales que comprenden cistationina | |
ATE301463T1 (de) | Pharmazeutische zusammensetzungen enthaltend 17alpha-furanylester von 17beta-carbothioat androstanderivaten und einen muskarinrezeptorantagonist | |
BR0206960A (pt) | Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose | |
BR0206922A (pt) | Compostos orgânicos | |
MXPA05000661A (es) | Composicion farmaceutica estable que comprende eritropoyetina. | |
HN2001000021A (es) | Nuevos derivados de amidas heterociclicas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |